Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes. - Test2 - elhamkhani - TriplyDB

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

http://www.wikidata.org/entity/Q33766277

about

Genetic variation and exercise-induced muscle damage: implications for athletic performance, injury and ageing Adipose extracellular matrix remodelling in obesity and insulin resistance Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy Osteopontin: At the cross-roads of myocyte survival and myocardial function Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue.Sex-Specific Muscular Maturation Responses Following Prenatal Exposure to Methylation-Related Micronutrients in Pigs Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Osteopontin activates the diabetes-associated potassium channel TALK-1 in pancreatic β-cells.AGEs induce ectopic endochondral ossification in intervertebral discs Osteopontin facilitates West Nile virus neuroinvasion via neutrophil "Trojan horse" transport Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.In Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose Tissue Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage Wogonin suppresses osteopontin expression in adipocytes by activating PPARα The Impact of Intramammary Escherichia coli Challenge on Liver and Mammary Transcriptome and Cross-Talk in Dairy Cows during Early Lactation Using RNAseq.Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism.Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.Matricellular proteins as regulators of cancer metastasis to bone.Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9.Association of Salivary Osteopontin Levels with Glycaemic Status and Microalbuminuria - in Patients with Type 2 Diabetes Mellitus.Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype Pyruvate Kinase M2: A Novel Biomarker for the Early Detection of Acute Kidney Injury.Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice.Osteopontin polymorphism increases gastric precancerous intestinal metaplasia susceptibility in Helicobacter pylori infected male.Serum Osteopontin Levels Are Decreased in Focal Adenomyosis.GSK3β negatively regulates LPS-induced osteopontin expression via inhibiting its transcription.Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties.Rat Urinary Osteopontin and Neutrophil Gelatinase-Associated Lipocalin Improve Certainty of Detecting Drug-Induced Kidney Injury.Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease.Osteopontin-stimulated apoptosis in cardiac myocytes involves oxidative stress and mitochondrial death pathway: role of a pro-apoptotic protein BIK.Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.Associations Between Salivary Bone Metabolism Markers and Periodontal Breakdown.Osteopontin at the Crossroads of Inflammation and Tumor Progression.Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome.Restoration of Visual Function by Enhancing Conduction in Regenerated Axons Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants.

P2860

Q26746405-A7221C6E-D398-4FFE-965A-0F505D110D81 Q28069494-8D5DE9AE-05DA-4E55-B773-EBC3CAA8135D Q28072006-5BA065E8-E94C-44E0-B508-C5404EAA6FE3 Q28248833-5B529009-2528-4069-BF16-7C8A9B58A25D Q30277975-1D11C35A-500C-441F-9C18-44FBEF7F037D Q30313528-222BF437-F87A-4D3F-9035-C23C531DA9D2 Q30360159-ED7A5833-8113-4391-A3D4-03A97EF74B24 Q30384899-5D93928B-A895-4107-938D-8A0938E1BC4D Q33558636-BFD3A214-B8C8-44C1-B704-382CF58CF6CE Q33828356-0C392EC0-2DF5-4AC9-A076-FF53EA2B4629 Q33875734-B5E105A7-56CB-4A2E-8BF5-0D5078484F86 Q35396061-713C4B6A-9ECF-4520-9604-605A8DDD1514 Q35603472-E213345E-F427-44E0-8E7D-E8EC1218FF9D Q35652638-25D80A95-E2AD-402D-BC5C-FD404BDF72BD Q35913508-F6A04C66-9F70-4B6E-98EA-02AC864B535E Q36044802-BAA41688-CABB-47D3-81D4-57BC2CBA7B42 Q36060054-0B1901CC-8A10-4000-A6FB-65B7FAEBF890 Q36433637-1A4C8B29-F778-42A9-A05E-1437217037EA Q36588292-BEF9DD40-EB65-4968-A67F-553ABA9D5336 Q36923653-FF802987-4629-448E-9589-E8CC5EC8AD7B Q36970239-2E0CF970-0E95-4AFD-996C-7924804AB5D6 Q37266699-CBCD4F50-546C-4A0F-A43F-FF241B4E77BB Q37368724-25277B70-3FF7-425F-A83B-8A7830E17055 Q37374329-8DDE825B-233F-4C7C-BC44-001C5BAC52DA Q38416197-8CDB547B-32C7-479C-A0D7-D747F420361C Q38618168-0F5DCE32-9ABA-4F69-8917-C992FB762A19 Q38661476-FC63A0D5-7F82-420C-9987-706C50E005DF Q38817047-8A6F731D-B4D0-44B7-810D-938CFFF45748 Q38922467-D4B62FF7-FD94-4AEB-90E7-89E371D48F39 Q39738927-CC5015F6-7928-474B-90D4-4CC7FDC60237 Q39878923-8239D635-BE3F-4750-9996-13C9AF0F91C3 Q40029271-FE7F1422-2493-4AE7-829C-61AB4B3782DF Q40218169-68C4A463-EC76-459A-8263-367A24769173 Q40645399-5CF5FFB6-1950-4219-B8FF-A8942B22B425 Q41045705-413E653A-1F86-44B9-950A-096F835B94E9 Q41095061-CD99382A-3F0A-4B6B-88FF-4FC485DE60EE Q41099667-0E530E6B-ECC2-482F-A6F9-BC3AC96E6665 Q41141093-77B75B46-DF1E-4CC0-A04D-174FAD5C8E52 Q41405823-CF5189A0-A7EB-4029-A96E-A1688A2BA9D6 Q41583867-E91CE517-366F-449E-9402-F12BAA3A492D

P2860

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

http://www.wikidata.org/entity/Q33766277

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@ast

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@en

type

label

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@ast

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@en

prefLabel

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@ast

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@en

P1433

Q33766277-2D4E7BC7-BFA8-4B42-805E-657429D8A53C

P1476

Q33766277-BD804CA6-F399-47E9-94CB-C01291854DD1

P2093

Q33766277-35BA52CE-986B-4AC5-82FD-5C3433BD3DE6

Q33766277-54668710-8E23-4FC4-8E03-D5298EEF7B1E

Q33766277-A476D09F-1A0D-4F92-ABA6-C8C6F63BD461

P2860

Q33766277-00DCB64B-E4A1-43DB-89A2-ECF9662437ED

Q33766277-01A70964-0724-44B2-B1F4-2382B07E9EB6

Q33766277-01DF25A6-A26B-4377-811F-2081F68EBB12

Q33766277-039646DD-B595-4EE9-B6A6-DEA1E4179C3A

Q33766277-04267F69-73BD-4372-ADA9-D6FA4F6A8DB7

Q33766277-0722D35B-5FCB-49FF-82A3-237608A034DD

Q33766277-082F8379-1BB8-45B6-8695-32D9D3B5D0AD

Q33766277-0958C89A-B9D8-4293-9775-B5ECFF093231

Q33766277-0B367404-C44E-4FF2-AFC6-F61B78EE2990

Q33766277-0F5B7D71-9CC4-45C1-BB97-4D31EB011B81

P304

Q33766277-E5DC9348-A70D-48DD-A341-5C5104880C6E

P31

Q33766277-BA3B3559-FC8D-4F99-9CF5-088FFDC1E0C4

P356

Q33766277-0EA784E0-32ED-47C3-B7C4-67D9F43E98D9

P433

Q33766277-0A8C80F9-A947-4250-BCA6-4E52975A2F6E

P478

Q33766277-1F664713-2ED9-49F6-BABE-0FC9BBBA4790

P577

Q33766277-63787B1F-8EB2-4E5C-9E55-8EB5D8FA51FE

P5875

Q33766277-D0AD7A7D-7AB9-4242-B8FE-9FB8F179E77D

P698

Q33766277-CA6F9AAC-6226-49BC-85FF-14FE6A60F3B9

P921

Q33766277-61CE2BC0-9B8C-4214-8679-3BAEE0E62AAC

P932

Q33766277-B744EB80-53D4-49F9-B58D-9FD918F34D12

P356

J.MOLMET.2014.03.004

P1433

Molecular Metabolism

P1476

Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.

@en

P2093

Dennis Bruemmer

http://www.w3.org/2001/XMLSchema#string

Florian Kahles

http://www.w3.org/2001/XMLSchema#string

Hannes M Findeisen

http://www.w3.org/2001/XMLSchema#string

P2860

Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells

Osteopontin--a possible anchor of osteoclasts to bone

Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin

Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts

Osteopontin-c is a selective marker of breast cancer

P304

384-393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLMET.2014.03.004

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260998140

http://www.w3.org/2001/XMLSchema#string

P698

24944898

http://www.w3.org/2001/XMLSchema#string

P921

P932

4060362

http://www.w3.org/2001/XMLSchema#string